International

Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its state-of-the-art spatial biology platform TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, an AI-powered...

Proscia and Visiopharm: Partnership to improve clinical decision making for breast and colon cancer care HOERSHOLM, Denmark & PHILADELPHIA – March 22, 2022 – Proscia®, a leader in digital and computational pathology solutions, and...

Linköping, Sweden – March 17, 2022 – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with Erasmus University Medical Center (Erasmus MC) in the Netherlands. The...

Milan, March 10th, 2022 – Dedalus Group ("Dedalus"), the leading healthcare and diagnostic software solutions provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer...

AIRA Matrix invites you to the 111th USCAP Annual Meeting, Los Angeles where we exhibit our novel Prostate Cancer Decision Support Suite from 21-23 March 2022. The suite comprising diagnostic, prognostic, and predictive solutions provides...

AIRA Matrix has published a new paper. Read on to learn more about their work. Our paper “A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies” has been published in the March...